nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0699	0.11	CbGbCtD
Citalopram—CYP2C19—Prednisone—ankylosing spondylitis	0.0525	0.0829	CbGbCtD
Citalopram—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0523	0.0826	CbGbCtD
Citalopram—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0516	0.0814	CbGbCtD
Citalopram—ABCB1—Betamethasone—ankylosing spondylitis	0.0455	0.0718	CbGbCtD
Citalopram—ABCB1—Prednisolone—ankylosing spondylitis	0.0448	0.0708	CbGbCtD
Citalopram—ABCB1—Prednisone—ankylosing spondylitis	0.0424	0.0669	CbGbCtD
Citalopram—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0419	0.0661	CbGbCtD
Citalopram—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0328	0.0517	CbGbCtD
Citalopram—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0317	0.0501	CbGbCtD
Citalopram—CYP3A4—Betamethasone—ankylosing spondylitis	0.0272	0.043	CbGbCtD
Citalopram—CYP3A4—Prednisolone—ankylosing spondylitis	0.0269	0.0424	CbGbCtD
Citalopram—ABCB1—Dexamethasone—ankylosing spondylitis	0.0264	0.0417	CbGbCtD
Citalopram—CYP3A4—Prednisone—ankylosing spondylitis	0.0254	0.0401	CbGbCtD
Citalopram—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0249	0.0393	CbGbCtD
Citalopram—ABCB1—Methotrexate—ankylosing spondylitis	0.0212	0.0336	CbGbCtD
Citalopram—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0158	0.025	CbGbCtD
Citalopram—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000199	0.000542	CcSEcCtD
Citalopram—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000199	0.000542	CcSEcCtD
Citalopram—Epistaxis—Methotrexate—ankylosing spondylitis	0.000199	0.000542	CcSEcCtD
Citalopram—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000199	0.000542	CcSEcCtD
Citalopram—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000199	0.000542	CcSEcCtD
Citalopram—Mental disorder—Prednisone—ankylosing spondylitis	0.000198	0.000541	CcSEcCtD
Citalopram—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000198	0.00054	CcSEcCtD
Citalopram—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000197	0.000538	CcSEcCtD
Citalopram—Erythema—Prednisone—ankylosing spondylitis	0.000197	0.000537	CcSEcCtD
Citalopram—Malnutrition—Prednisone—ankylosing spondylitis	0.000197	0.000537	CcSEcCtD
Citalopram—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000197	0.000536	CcSEcCtD
Citalopram—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000197	0.000536	CcSEcCtD
Citalopram—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000196	0.000535	CcSEcCtD
Citalopram—Convulsion—Dexamethasone—ankylosing spondylitis	0.000196	0.000535	CcSEcCtD
Citalopram—Convulsion—Betamethasone—ankylosing spondylitis	0.000196	0.000535	CcSEcCtD
Citalopram—Hypertension—Dexamethasone—ankylosing spondylitis	0.000195	0.000533	CcSEcCtD
Citalopram—Hypertension—Betamethasone—ankylosing spondylitis	0.000195	0.000533	CcSEcCtD
Citalopram—Myalgia—Dexamethasone—ankylosing spondylitis	0.000193	0.000525	CcSEcCtD
Citalopram—Myalgia—Betamethasone—ankylosing spondylitis	0.000193	0.000525	CcSEcCtD
Citalopram—Anxiety—Betamethasone—ankylosing spondylitis	0.000192	0.000523	CcSEcCtD
Citalopram—Anxiety—Dexamethasone—ankylosing spondylitis	0.000192	0.000523	CcSEcCtD
Citalopram—Discomfort—Dexamethasone—ankylosing spondylitis	0.00019	0.000519	CcSEcCtD
Citalopram—Discomfort—Betamethasone—ankylosing spondylitis	0.00019	0.000519	CcSEcCtD
Citalopram—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00019	0.000518	CcSEcCtD
Citalopram—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00019	0.000517	CcSEcCtD
Citalopram—Pain—Prednisolone—ankylosing spondylitis	0.000189	0.000516	CcSEcCtD
Citalopram—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000189	0.000516	CcSEcCtD
Citalopram—Hepatitis—Methotrexate—ankylosing spondylitis	0.000189	0.000516	CcSEcCtD
Citalopram—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000188	0.000512	CcSEcCtD
Citalopram—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000187	0.000509	CcSEcCtD
Citalopram—Vision blurred—Prednisone—ankylosing spondylitis	0.000186	0.000506	CcSEcCtD
Citalopram—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000185	0.000506	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000185	0.000506	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000185	0.000504	CcSEcCtD
Citalopram—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000185	0.000504	CcSEcCtD
Citalopram—Oedema—Dexamethasone—ankylosing spondylitis	0.000185	0.000504	CcSEcCtD
Citalopram—Oedema—Betamethasone—ankylosing spondylitis	0.000185	0.000504	CcSEcCtD
Citalopram—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000185	0.000504	CcSEcCtD
Citalopram—Insomnia—Triamcinolone—ankylosing spondylitis	0.000184	0.000502	CcSEcCtD
Citalopram—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000184	0.000501	CcSEcCtD
Citalopram—Infection—Dexamethasone—ankylosing spondylitis	0.000183	0.0005	CcSEcCtD
Citalopram—Infection—Betamethasone—ankylosing spondylitis	0.000183	0.0005	CcSEcCtD
Citalopram—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000183	0.000499	CcSEcCtD
Citalopram—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000183	0.000498	CcSEcCtD
Citalopram—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000182	0.000497	CcSEcCtD
Citalopram—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000182	0.000497	CcSEcCtD
Citalopram—Visual impairment—Methotrexate—ankylosing spondylitis	0.000182	0.000497	CcSEcCtD
Citalopram—Anaemia—Prednisone—ankylosing spondylitis	0.000182	0.000497	CcSEcCtD
Citalopram—Shock—Dexamethasone—ankylosing spondylitis	0.000182	0.000495	CcSEcCtD
Citalopram—Shock—Betamethasone—ankylosing spondylitis	0.000182	0.000495	CcSEcCtD
Citalopram—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000181	0.000495	CcSEcCtD
Citalopram—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000181	0.000494	CcSEcCtD
Citalopram—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000181	0.000494	CcSEcCtD
Citalopram—Agitation—Prednisone—ankylosing spondylitis	0.000181	0.000494	CcSEcCtD
Citalopram—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000181	0.000493	CcSEcCtD
Citalopram—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000181	0.000493	CcSEcCtD
Citalopram—Tachycardia—Betamethasone—ankylosing spondylitis	0.00018	0.000491	CcSEcCtD
Citalopram—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00018	0.000491	CcSEcCtD
Citalopram—Angioedema—Prednisone—ankylosing spondylitis	0.00018	0.000491	CcSEcCtD
Citalopram—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000179	0.000488	CcSEcCtD
Citalopram—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000179	0.000488	CcSEcCtD
Citalopram—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000179	0.000487	CcSEcCtD
Citalopram—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000179	0.000487	CcSEcCtD
Citalopram—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000179	0.000487	CcSEcCtD
Citalopram—Malaise—Prednisone—ankylosing spondylitis	0.000178	0.000485	CcSEcCtD
Citalopram—Vertigo—Prednisone—ankylosing spondylitis	0.000177	0.000483	CcSEcCtD
Citalopram—Eye disorder—Methotrexate—ankylosing spondylitis	0.000177	0.000482	CcSEcCtD
Citalopram—Syncope—Prednisone—ankylosing spondylitis	0.000177	0.000482	CcSEcCtD
Citalopram—Tinnitus—Methotrexate—ankylosing spondylitis	0.000176	0.000481	CcSEcCtD
Citalopram—Anorexia—Betamethasone—ankylosing spondylitis	0.000176	0.00048	CcSEcCtD
Citalopram—Anorexia—Dexamethasone—ankylosing spondylitis	0.000176	0.00048	CcSEcCtD
Citalopram—Urticaria—Prednisolone—ankylosing spondylitis	0.000176	0.000479	CcSEcCtD
Citalopram—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000176	0.000479	CcSEcCtD
Citalopram—Fatigue—Triamcinolone—ankylosing spondylitis	0.000175	0.000478	CcSEcCtD
Citalopram—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000175	0.000477	CcSEcCtD
Citalopram—Pain—Triamcinolone—ankylosing spondylitis	0.000174	0.000475	CcSEcCtD
Citalopram—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000173	0.000472	CcSEcCtD
Citalopram—Hypotension—Dexamethasone—ankylosing spondylitis	0.000173	0.00047	CcSEcCtD
Citalopram—Hypotension—Betamethasone—ankylosing spondylitis	0.000173	0.00047	CcSEcCtD
Citalopram—Angiopathy—Methotrexate—ankylosing spondylitis	0.000172	0.000468	CcSEcCtD
Citalopram—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000171	0.000466	CcSEcCtD
Citalopram—Convulsion—Prednisone—ankylosing spondylitis	0.000171	0.000466	CcSEcCtD
Citalopram—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00017	0.000465	CcSEcCtD
Citalopram—Hypertension—Prednisone—ankylosing spondylitis	0.00017	0.000464	CcSEcCtD
Citalopram—Chills—Methotrexate—ankylosing spondylitis	0.00017	0.000463	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000168	0.000459	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000168	0.000459	CcSEcCtD
Citalopram—Arthralgia—Prednisone—ankylosing spondylitis	0.000168	0.000457	CcSEcCtD
Citalopram—Myalgia—Prednisone—ankylosing spondylitis	0.000168	0.000457	CcSEcCtD
Citalopram—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000168	0.000457	CcSEcCtD
Citalopram—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000167	0.000456	CcSEcCtD
Citalopram—Anxiety—Prednisone—ankylosing spondylitis	0.000167	0.000456	CcSEcCtD
Citalopram—Alopecia—Methotrexate—ankylosing spondylitis	0.000167	0.000456	CcSEcCtD
Citalopram—Insomnia—Betamethasone—ankylosing spondylitis	0.000167	0.000455	CcSEcCtD
Citalopram—Insomnia—Dexamethasone—ankylosing spondylitis	0.000167	0.000455	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000167	0.000454	CcSEcCtD
Citalopram—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000166	0.000453	CcSEcCtD
Citalopram—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000166	0.000452	CcSEcCtD
Citalopram—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000166	0.000452	CcSEcCtD
Citalopram—Discomfort—Prednisone—ankylosing spondylitis	0.000166	0.000452	CcSEcCtD
Citalopram—Mental disorder—Methotrexate—ankylosing spondylitis	0.000166	0.000452	CcSEcCtD
Citalopram—Erythema—Methotrexate—ankylosing spondylitis	0.000165	0.000449	CcSEcCtD
Citalopram—Malnutrition—Methotrexate—ankylosing spondylitis	0.000165	0.000449	CcSEcCtD
Citalopram—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000163	0.000445	CcSEcCtD
Citalopram—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000163	0.000443	CcSEcCtD
Citalopram—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000163	0.000443	CcSEcCtD
Citalopram—Urticaria—Triamcinolone—ankylosing spondylitis	0.000162	0.000441	CcSEcCtD
Citalopram—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000161	0.00044	CcSEcCtD
Citalopram—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000161	0.00044	CcSEcCtD
Citalopram—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000161	0.000439	CcSEcCtD
Citalopram—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000161	0.000438	CcSEcCtD
Citalopram—Oedema—Prednisone—ankylosing spondylitis	0.000161	0.000438	CcSEcCtD
Citalopram—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000161	0.000438	CcSEcCtD
Citalopram—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000161	0.000438	CcSEcCtD
Citalopram—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000161	0.000438	CcSEcCtD
Citalopram—Infection—Prednisone—ankylosing spondylitis	0.00016	0.000436	CcSEcCtD
Citalopram—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000159	0.000435	CcSEcCtD
Citalopram—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000159	0.000435	CcSEcCtD
Citalopram—Back pain—Methotrexate—ankylosing spondylitis	0.000159	0.000434	CcSEcCtD
Citalopram—Fatigue—Betamethasone—ankylosing spondylitis	0.000159	0.000434	CcSEcCtD
Citalopram—Fatigue—Dexamethasone—ankylosing spondylitis	0.000159	0.000434	CcSEcCtD
Citalopram—Shock—Prednisone—ankylosing spondylitis	0.000158	0.000431	CcSEcCtD
Citalopram—Pain—Betamethasone—ankylosing spondylitis	0.000158	0.000431	CcSEcCtD
Citalopram—Pain—Dexamethasone—ankylosing spondylitis	0.000158	0.000431	CcSEcCtD
Citalopram—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000158	0.00043	CcSEcCtD
Citalopram—Tachycardia—Prednisone—ankylosing spondylitis	0.000157	0.000428	CcSEcCtD
Citalopram—Skin disorder—Prednisone—ankylosing spondylitis	0.000156	0.000426	CcSEcCtD
Citalopram—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000155	0.000424	CcSEcCtD
Citalopram—Vision blurred—Methotrexate—ankylosing spondylitis	0.000155	0.000423	CcSEcCtD
Citalopram—Anorexia—Prednisone—ankylosing spondylitis	0.000153	0.000418	CcSEcCtD
Citalopram—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000153	0.000417	CcSEcCtD
Citalopram—Anaemia—Methotrexate—ankylosing spondylitis	0.000152	0.000415	CcSEcCtD
Citalopram—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000152	0.000415	CcSEcCtD
Citalopram—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000152	0.000415	CcSEcCtD
Citalopram—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000151	0.000412	CcSEcCtD
Citalopram—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000151	0.000412	CcSEcCtD
Citalopram—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00015	0.000409	CcSEcCtD
Citalopram—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00015	0.000408	CcSEcCtD
Citalopram—Malaise—Methotrexate—ankylosing spondylitis	0.000148	0.000405	CcSEcCtD
Citalopram—Vertigo—Methotrexate—ankylosing spondylitis	0.000148	0.000403	CcSEcCtD
Citalopram—Leukopenia—Methotrexate—ankylosing spondylitis	0.000147	0.000402	CcSEcCtD
Citalopram—Urticaria—Betamethasone—ankylosing spondylitis	0.000147	0.0004	CcSEcCtD
Citalopram—Urticaria—Dexamethasone—ankylosing spondylitis	0.000147	0.0004	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000147	0.000399	CcSEcCtD
Citalopram—Dizziness—Prednisolone—ankylosing spondylitis	0.000146	0.000399	CcSEcCtD
Citalopram—Asthenia—Triamcinolone—ankylosing spondylitis	0.000146	0.000398	CcSEcCtD
Citalopram—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000146	0.000398	CcSEcCtD
Citalopram—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000146	0.000398	CcSEcCtD
Citalopram—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000146	0.000398	CcSEcCtD
Citalopram—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000146	0.000398	CcSEcCtD
Citalopram—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000146	0.000397	CcSEcCtD
Citalopram—Insomnia—Prednisone—ankylosing spondylitis	0.000145	0.000397	CcSEcCtD
Citalopram—Paraesthesia—Prednisone—ankylosing spondylitis	0.000144	0.000394	CcSEcCtD
Citalopram—Pruritus—Triamcinolone—ankylosing spondylitis	0.000144	0.000393	CcSEcCtD
Citalopram—Cough—Methotrexate—ankylosing spondylitis	0.000144	0.000392	CcSEcCtD
Citalopram—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000144	0.000392	CcSEcCtD
Citalopram—Convulsion—Methotrexate—ankylosing spondylitis	0.000143	0.000389	CcSEcCtD
Citalopram—Dyspepsia—Prednisone—ankylosing spondylitis	0.000142	0.000386	CcSEcCtD
Citalopram—Chest pain—Methotrexate—ankylosing spondylitis	0.00014	0.000382	CcSEcCtD
Citalopram—Arthralgia—Methotrexate—ankylosing spondylitis	0.00014	0.000382	CcSEcCtD
Citalopram—Myalgia—Methotrexate—ankylosing spondylitis	0.00014	0.000382	CcSEcCtD
Citalopram—Decreased appetite—Prednisone—ankylosing spondylitis	0.00014	0.000381	CcSEcCtD
Citalopram—Rash—Prednisolone—ankylosing spondylitis	0.00014	0.00038	CcSEcCtD
Citalopram—Dermatitis—Prednisolone—ankylosing spondylitis	0.000139	0.00038	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000139	0.00038	CcSEcCtD
Citalopram—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000139	0.000379	CcSEcCtD
Citalopram—Fatigue—Prednisone—ankylosing spondylitis	0.000139	0.000378	CcSEcCtD
Citalopram—Headache—Prednisolone—ankylosing spondylitis	0.000139	0.000378	CcSEcCtD
Citalopram—Discomfort—Methotrexate—ankylosing spondylitis	0.000139	0.000378	CcSEcCtD
Citalopram—Constipation—Prednisone—ankylosing spondylitis	0.000138	0.000375	CcSEcCtD
Citalopram—Confusional state—Methotrexate—ankylosing spondylitis	0.000136	0.00037	CcSEcCtD
Citalopram—Dizziness—Triamcinolone—ankylosing spondylitis	0.000135	0.000367	CcSEcCtD
Citalopram—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000134	0.000366	CcSEcCtD
Citalopram—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000134	0.000366	CcSEcCtD
Citalopram—Infection—Methotrexate—ankylosing spondylitis	0.000134	0.000364	CcSEcCtD
Citalopram—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000133	0.000361	CcSEcCtD
Citalopram—Asthenia—Betamethasone—ankylosing spondylitis	0.000132	0.000361	CcSEcCtD
Citalopram—Asthenia—Dexamethasone—ankylosing spondylitis	0.000132	0.000361	CcSEcCtD
Citalopram—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000132	0.000359	CcSEcCtD
Citalopram—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000132	0.000359	CcSEcCtD
Citalopram—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000131	0.000359	CcSEcCtD
Citalopram—Nausea—Prednisolone—ankylosing spondylitis	0.000131	0.000358	CcSEcCtD
Citalopram—Pruritus—Dexamethasone—ankylosing spondylitis	0.000131	0.000356	CcSEcCtD
Citalopram—Pruritus—Betamethasone—ankylosing spondylitis	0.000131	0.000356	CcSEcCtD
Citalopram—Skin disorder—Methotrexate—ankylosing spondylitis	0.000131	0.000356	CcSEcCtD
Citalopram—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00013	0.000354	CcSEcCtD
Citalopram—Vomiting—Triamcinolone—ankylosing spondylitis	0.000129	0.000353	CcSEcCtD
Citalopram—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000129	0.000352	CcSEcCtD
Citalopram—Rash—Triamcinolone—ankylosing spondylitis	0.000128	0.00035	CcSEcCtD
Citalopram—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000128	0.00035	CcSEcCtD
Citalopram—Anorexia—Methotrexate—ankylosing spondylitis	0.000128	0.000349	CcSEcCtD
Citalopram—Rash—Methylprednisolone—ankylosing spondylitis	0.000128	0.000349	CcSEcCtD
Citalopram—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000128	0.000349	CcSEcCtD
Citalopram—Urticaria—Prednisone—ankylosing spondylitis	0.000128	0.000348	CcSEcCtD
Citalopram—Headache—Triamcinolone—ankylosing spondylitis	0.000127	0.000348	CcSEcCtD
Citalopram—Headache—Methylprednisolone—ankylosing spondylitis	0.000127	0.000347	CcSEcCtD
Citalopram—Abdominal pain—Prednisone—ankylosing spondylitis	0.000127	0.000347	CcSEcCtD
Citalopram—Body temperature increased—Prednisone—ankylosing spondylitis	0.000127	0.000347	CcSEcCtD
Citalopram—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000126	0.000345	CcSEcCtD
Citalopram—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000126	0.000345	CcSEcCtD
Citalopram—Hypotension—Methotrexate—ankylosing spondylitis	0.000126	0.000342	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000122	0.000334	CcSEcCtD
Citalopram—Dizziness—Dexamethasone—ankylosing spondylitis	0.000122	0.000333	CcSEcCtD
Citalopram—Dizziness—Betamethasone—ankylosing spondylitis	0.000122	0.000333	CcSEcCtD
Citalopram—Insomnia—Methotrexate—ankylosing spondylitis	0.000122	0.000331	CcSEcCtD
Citalopram—Nausea—Triamcinolone—ankylosing spondylitis	0.000121	0.00033	CcSEcCtD
Citalopram—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000121	0.000329	CcSEcCtD
Citalopram—Nausea—Methylprednisolone—ankylosing spondylitis	0.000121	0.000329	CcSEcCtD
Citalopram—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00012	0.000327	CcSEcCtD
Citalopram—Somnolence—Methotrexate—ankylosing spondylitis	0.000119	0.000326	CcSEcCtD
Citalopram—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000118	0.000323	CcSEcCtD
Citalopram—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000118	0.000323	CcSEcCtD
Citalopram—Vomiting—Betamethasone—ankylosing spondylitis	0.000117	0.00032	CcSEcCtD
Citalopram—Vomiting—Dexamethasone—ankylosing spondylitis	0.000117	0.00032	CcSEcCtD
Citalopram—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000117	0.000319	CcSEcCtD
Citalopram—Rash—Betamethasone—ankylosing spondylitis	0.000116	0.000317	CcSEcCtD
Citalopram—Rash—Dexamethasone—ankylosing spondylitis	0.000116	0.000317	CcSEcCtD
Citalopram—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000116	0.000317	CcSEcCtD
Citalopram—Dermatitis—Betamethasone—ankylosing spondylitis	0.000116	0.000317	CcSEcCtD
Citalopram—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000116	0.000316	CcSEcCtD
Citalopram—Fatigue—Methotrexate—ankylosing spondylitis	0.000116	0.000316	CcSEcCtD
Citalopram—Headache—Betamethasone—ankylosing spondylitis	0.000116	0.000315	CcSEcCtD
Citalopram—Headache—Dexamethasone—ankylosing spondylitis	0.000116	0.000315	CcSEcCtD
Citalopram—Asthenia—Prednisone—ankylosing spondylitis	0.000115	0.000315	CcSEcCtD
Citalopram—Pain—Methotrexate—ankylosing spondylitis	0.000115	0.000313	CcSEcCtD
Citalopram—Pruritus—Prednisone—ankylosing spondylitis	0.000114	0.00031	CcSEcCtD
Citalopram—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000111	0.000302	CcSEcCtD
Citalopram—Diarrhoea—Prednisone—ankylosing spondylitis	0.00011	0.0003	CcSEcCtD
Citalopram—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00011	0.0003	CcSEcCtD
Citalopram—Nausea—Betamethasone—ankylosing spondylitis	0.00011	0.000299	CcSEcCtD
Citalopram—Nausea—Dexamethasone—ankylosing spondylitis	0.00011	0.000299	CcSEcCtD
Citalopram—Urticaria—Methotrexate—ankylosing spondylitis	0.000107	0.000291	CcSEcCtD
Citalopram—Dizziness—Prednisone—ankylosing spondylitis	0.000106	0.00029	CcSEcCtD
Citalopram—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000106	0.00029	CcSEcCtD
Citalopram—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000106	0.00029	CcSEcCtD
Citalopram—Vomiting—Prednisone—ankylosing spondylitis	0.000102	0.000279	CcSEcCtD
Citalopram—Rash—Prednisone—ankylosing spondylitis	0.000101	0.000276	CcSEcCtD
Citalopram—Dermatitis—Prednisone—ankylosing spondylitis	0.000101	0.000276	CcSEcCtD
Citalopram—Headache—Prednisone—ankylosing spondylitis	0.000101	0.000275	CcSEcCtD
Citalopram—Hypersensitivity—Methotrexate—ankylosing spondylitis	9.9e-05	0.00027	CcSEcCtD
Citalopram—Asthenia—Methotrexate—ankylosing spondylitis	9.64e-05	0.000263	CcSEcCtD
Citalopram—Nausea—Prednisone—ankylosing spondylitis	9.55e-05	0.00026	CcSEcCtD
Citalopram—Pruritus—Methotrexate—ankylosing spondylitis	9.51e-05	0.000259	CcSEcCtD
Citalopram—Diarrhoea—Methotrexate—ankylosing spondylitis	9.2e-05	0.000251	CcSEcCtD
Citalopram—Dizziness—Methotrexate—ankylosing spondylitis	8.89e-05	0.000242	CcSEcCtD
Citalopram—Vomiting—Methotrexate—ankylosing spondylitis	8.55e-05	0.000233	CcSEcCtD
Citalopram—Rash—Methotrexate—ankylosing spondylitis	8.47e-05	0.000231	CcSEcCtD
Citalopram—Dermatitis—Methotrexate—ankylosing spondylitis	8.47e-05	0.000231	CcSEcCtD
Citalopram—Headache—Methotrexate—ankylosing spondylitis	8.42e-05	0.00023	CcSEcCtD
Citalopram—Nausea—Methotrexate—ankylosing spondylitis	7.98e-05	0.000218	CcSEcCtD
